The Infusion System Market can achieve 4.9% CAGR during the forecast period (2017-2025) and reach a substantial market worth by the end of 2025. Infusion System Market information, by product type (IV disposable, Infusion Pump, Others); by application (chemotherapy, diabetes, gastrointestinal diseases, pediatrics, and others); by end user (hospitals, specialty oncology wards, homecare) – Forecast to 2025
Infusion System Market – Insights
The Infusion System Market is pacing ahead with its increasing application in the military medical unit. Infusion systems are mostly used in infusing drugs, fluids, or nutrients into the circulatory system of a patient. Mostly done intravenously, but subcutaneous, arterial, and epidural are also common practices.
For sure, the prevalence of chronic diseases across the world is going to trigger a positive response from the healthcare sector that would assist the infusion system market in growth during the forecast period. Advanced technologies are going to play a pivotal role as well and make way for a smoother growth. Military medical services sector can also generate substantial revenue for the global market in the coming years.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1210
Infusion System Market – Key Players
Some of the key players in this market are:
- BRAUN MELSUNGEN AG
- Becton, Dickinson and Company
- Fresenius Kabi AG
- ICU Medical, Inc.
- Smith’s Medical
- Terumo Medical Corporation
Infusion System Market – Regional Analysis
Geographically, the Infusion System Market spans across North America, Europe, Asia Pacific, and the Middle East and Africa.
Among all the regions, North America is estimated to hold the largest market share and is expected to maintain its dominance over the review period owing to the continuous rise in advanced technologies in this region. While Europe holds the second position in the market, Asia Pacific is predicted to be the fastest growing market due to growing economies and huge opportunities in this region. The rapid growth in this region is mainly due to the developments in the healthcare sector along with disposable income per individual and improving economies.
The Middle East and African region account for the least market share owing to extremely low income and less economic development in this region.
Infusion System Market – Segmentation
The Global Infusion System Market has been segmented based on product type, application, end-user, and region.
By mode of product type, the global infusion system market has been segmented into infusion pump, IV disposal, and others. Among these, the IV disposal segment accounts for the largest market share.
By mode of application, the global infusion system market has been segmented into diabetes, gastrointestinal diseases, chemotherapy, pediatrics, and others. Among these, the segment for chemotherapy accounts for the largest market share.
By mode of end-users, the global infusion system market has been segmented into specialty oncology wards, hospitals, homecare, and others. Among these, the hospital segment dominates the global market.
Infusion System Market – Key Finding
- The Infusion System Global Market is expected to reach $44.33 Billion by 2025.
- IV disposable holds the largest share of 66.7% of the market.
- North America holds the largest market share of Infusion System market and is anticipated to reach $15.79 billion by the end of forecast period.
- Globally, Asia-Pacific is the fastest growing region and expected to grow at the rate of 5.3% during the forecast period.
Latest Industry News:
Aiming to reinvent the infusion process, Eli Probst and Todd Metlen have teamed up to design and develop the Infuzi Brio, the world’s first ultrasonic infuser. The Infuzi Brio uses ultrasonic technology to infuse the flavor of fruit, herbs, nuts, and spices into liquor in a matter of hours, instead of days or weeks. 14 SEP 2018
Amgen has announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for BLINCYTO® (blinatumomab) for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). The dosage of BLINCYTO via infusion treats ALL. 25 SEP 2018.
Browse Complete 168 Pages Premium Research Report Enabled with 100+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/infusion-systems-market-1210
About Market Research Future:
At Market Research Future (MRFR), We Enable Our Customers To Unravel The Complexity Of Various Industries Through Our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), And Market Research & Consulting Services.
In Order To Stay Updated With Technology And Work Process Of The Industry, MRFR Often Plans & Conducts Meet With The Industry Experts And Industrial Visits For Its Research Analyst Members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312